0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hereditary Disease Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29T15229
Home | Market Reports | Health| Health Conditions
Global Hereditary Disease Testing Market Research Report 2023
BUY CHAPTERS

Global Hereditary Disease Testing Market Research Report 2025

Code: QYRE-Auto-29T15229
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hereditary Disease Testing Market

The global market for Hereditary Disease Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Hereditary Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hereditary Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Hereditary Disease Testing in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Hereditary Disease Testing include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical, Agilent Technologies, Thermo Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hereditary Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Disease Testing.
The Hereditary Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hereditary Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hereditary Disease Testing Market Report

Report Metric Details
Report Name Hereditary Disease Testing Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Laboratory
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical, Agilent Technologies, Thermo Fisher Scientific, Twist Bioscience, Sophia Genetics, Fulgent Genetic, Medgenome, CENTOGENE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hereditary Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hereditary Disease Testing Market report?

Ans: The main players in the Hereditary Disease Testing Market are Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical, Agilent Technologies, Thermo Fisher Scientific, Twist Bioscience, Sophia Genetics, Fulgent Genetic, Medgenome, CENTOGENE

What are the Application segmentation covered in the Hereditary Disease Testing Market report?

Ans: The Applications covered in the Hereditary Disease Testing Market report are Hospital, Clinic, Laboratory, Others

What are the Type segmentation covered in the Hereditary Disease Testing Market report?

Ans: The Types covered in the Hereditary Disease Testing Market report are Hereditary Cancer Testing, Hereditary Non-cancer Testing

Recommended Reports

Genetic Testing Markets

Cancer Genetic Testing

Disease Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hereditary Cancer Testing
1.2.3 Hereditary Non-cancer Testing
1.3 Market by Application
1.3.1 Global Hereditary Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Disease Testing Market Perspective (2020-2031)
2.2 Global Hereditary Disease Testing Growth Trends by Region
2.2.1 Global Hereditary Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hereditary Disease Testing Historic Market Size by Region (2020-2025)
2.2.3 Hereditary Disease Testing Forecasted Market Size by Region (2026-2031)
2.3 Hereditary Disease Testing Market Dynamics
2.3.1 Hereditary Disease Testing Industry Trends
2.3.2 Hereditary Disease Testing Market Drivers
2.3.3 Hereditary Disease Testing Market Challenges
2.3.4 Hereditary Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Disease Testing Players by Revenue
3.1.1 Global Top Hereditary Disease Testing Players by Revenue (2020-2025)
3.1.2 Global Hereditary Disease Testing Revenue Market Share by Players (2020-2025)
3.2 Global Hereditary Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hereditary Disease Testing Revenue
3.4 Global Hereditary Disease Testing Market Concentration Ratio
3.4.1 Global Hereditary Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Disease Testing Revenue in 2024
3.5 Global Key Players of Hereditary Disease Testing Head office and Area Served
3.6 Global Key Players of Hereditary Disease Testing, Product and Application
3.7 Global Key Players of Hereditary Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Disease Testing Breakdown Data by Type
4.1 Global Hereditary Disease Testing Historic Market Size by Type (2020-2025)
4.2 Global Hereditary Disease Testing Forecasted Market Size by Type (2026-2031)
5 Hereditary Disease Testing Breakdown Data by Application
5.1 Global Hereditary Disease Testing Historic Market Size by Application (2020-2025)
5.2 Global Hereditary Disease Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hereditary Disease Testing Market Size (2020-2031)
6.2 North America Hereditary Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hereditary Disease Testing Market Size by Country (2020-2025)
6.4 North America Hereditary Disease Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Disease Testing Market Size (2020-2031)
7.2 Europe Hereditary Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hereditary Disease Testing Market Size by Country (2020-2025)
7.4 Europe Hereditary Disease Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Disease Testing Market Size (2020-2031)
8.2 Asia-Pacific Hereditary Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Hereditary Disease Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hereditary Disease Testing Market Size (2020-2031)
9.2 Latin America Hereditary Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hereditary Disease Testing Market Size by Country (2020-2025)
9.4 Latin America Hereditary Disease Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Disease Testing Market Size (2020-2031)
10.2 Middle East & Africa Hereditary Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Hereditary Disease Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Hereditary Disease Testing Introduction
11.1.4 Myriad Genetics Revenue in Hereditary Disease Testing Business (2020-2025)
11.1.5 Myriad Genetics Recent Development
11.2 Invitae
11.2.1 Invitae Company Details
11.2.2 Invitae Business Overview
11.2.3 Invitae Hereditary Disease Testing Introduction
11.2.4 Invitae Revenue in Hereditary Disease Testing Business (2020-2025)
11.2.5 Invitae Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Hereditary Disease Testing Introduction
11.3.4 Illumina Revenue in Hereditary Disease Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Natera
11.4.1 Natera Company Details
11.4.2 Natera Business Overview
11.4.3 Natera Hereditary Disease Testing Introduction
11.4.4 Natera Revenue in Hereditary Disease Testing Business (2020-2025)
11.4.5 Natera Recent Development
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Details
11.5.2 Laboratory Corporation of America Holdings Business Overview
11.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Introduction
11.5.4 Laboratory Corporation of America Holdings Revenue in Hereditary Disease Testing Business (2020-2025)
11.5.5 Laboratory Corporation of America Holdings Recent Development
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Introduction
11.6.4 F. Hoffmann-La Roche Revenue in Hereditary Disease Testing Business (2020-2025)
11.6.5 F. Hoffmann-La Roche Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Hereditary Disease Testing Introduction
11.7.4 Quest Diagnostics Revenue in Hereditary Disease Testing Business (2020-2025)
11.7.5 Quest Diagnostics Recent Development
11.8 CooperSurgical
11.8.1 CooperSurgical Company Details
11.8.2 CooperSurgical Business Overview
11.8.3 CooperSurgical Hereditary Disease Testing Introduction
11.8.4 CooperSurgical Revenue in Hereditary Disease Testing Business (2020-2025)
11.8.5 CooperSurgical Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Hereditary Disease Testing Introduction
11.9.4 Agilent Technologies Revenue in Hereditary Disease Testing Business (2020-2025)
11.9.5 Agilent Technologies Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Hereditary Disease Testing Introduction
11.10.4 Thermo Fisher Scientific Revenue in Hereditary Disease Testing Business (2020-2025)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Twist Bioscience
11.11.1 Twist Bioscience Company Details
11.11.2 Twist Bioscience Business Overview
11.11.3 Twist Bioscience Hereditary Disease Testing Introduction
11.11.4 Twist Bioscience Revenue in Hereditary Disease Testing Business (2020-2025)
11.11.5 Twist Bioscience Recent Development
11.12 Sophia Genetics
11.12.1 Sophia Genetics Company Details
11.12.2 Sophia Genetics Business Overview
11.12.3 Sophia Genetics Hereditary Disease Testing Introduction
11.12.4 Sophia Genetics Revenue in Hereditary Disease Testing Business (2020-2025)
11.12.5 Sophia Genetics Recent Development
11.13 Fulgent Genetic
11.13.1 Fulgent Genetic Company Details
11.13.2 Fulgent Genetic Business Overview
11.13.3 Fulgent Genetic Hereditary Disease Testing Introduction
11.13.4 Fulgent Genetic Revenue in Hereditary Disease Testing Business (2020-2025)
11.13.5 Fulgent Genetic Recent Development
11.14 Medgenome
11.14.1 Medgenome Company Details
11.14.2 Medgenome Business Overview
11.14.3 Medgenome Hereditary Disease Testing Introduction
11.14.4 Medgenome Revenue in Hereditary Disease Testing Business (2020-2025)
11.14.5 Medgenome Recent Development
11.15 CENTOGENE
11.15.1 CENTOGENE Company Details
11.15.2 CENTOGENE Business Overview
11.15.3 CENTOGENE Hereditary Disease Testing Introduction
11.15.4 CENTOGENE Revenue in Hereditary Disease Testing Business (2020-2025)
11.15.5 CENTOGENE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Hereditary Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hereditary Cancer Testing
 Table 3. Key Players of Hereditary Non-cancer Testing
 Table 4. Global Hereditary Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Hereditary Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Hereditary Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Hereditary Disease Testing Market Share by Region (2020-2025)
 Table 8. Global Hereditary Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Hereditary Disease Testing Market Share by Region (2026-2031)
 Table 10. Hereditary Disease Testing Market Trends
 Table 11. Hereditary Disease Testing Market Drivers
 Table 12. Hereditary Disease Testing Market Challenges
 Table 13. Hereditary Disease Testing Market Restraints
 Table 14. Global Hereditary Disease Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Hereditary Disease Testing Market Share by Players (2020-2025)
 Table 16. Global Top Hereditary Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Disease Testing as of 2024)
 Table 17. Ranking of Global Top Hereditary Disease Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Hereditary Disease Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Hereditary Disease Testing, Headquarters and Area Served
 Table 20. Global Key Players of Hereditary Disease Testing, Product and Application
 Table 21. Global Key Players of Hereditary Disease Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Hereditary Disease Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Hereditary Disease Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Hereditary Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Hereditary Disease Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Hereditary Disease Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Hereditary Disease Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Hereditary Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Hereditary Disease Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Hereditary Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Hereditary Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Hereditary Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Hereditary Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Hereditary Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Hereditary Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Hereditary Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Hereditary Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Hereditary Disease Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hereditary Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Hereditary Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Hereditary Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Hereditary Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Hereditary Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Hereditary Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Myriad Genetics Company Details
 Table 47. Myriad Genetics Business Overview
 Table 48. Myriad Genetics Hereditary Disease Testing Product
 Table 49. Myriad Genetics Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 50. Myriad Genetics Recent Development
 Table 51. Invitae Company Details
 Table 52. Invitae Business Overview
 Table 53. Invitae Hereditary Disease Testing Product
 Table 54. Invitae Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 55. Invitae Recent Development
 Table 56. Illumina Company Details
 Table 57. Illumina Business Overview
 Table 58. Illumina Hereditary Disease Testing Product
 Table 59. Illumina Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 60. Illumina Recent Development
 Table 61. Natera Company Details
 Table 62. Natera Business Overview
 Table 63. Natera Hereditary Disease Testing Product
 Table 64. Natera Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 65. Natera Recent Development
 Table 66. Laboratory Corporation of America Holdings Company Details
 Table 67. Laboratory Corporation of America Holdings Business Overview
 Table 68. Laboratory Corporation of America Holdings Hereditary Disease Testing Product
 Table 69. Laboratory Corporation of America Holdings Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 70. Laboratory Corporation of America Holdings Recent Development
 Table 71. F. Hoffmann-La Roche Company Details
 Table 72. F. Hoffmann-La Roche Business Overview
 Table 73. F. Hoffmann-La Roche Hereditary Disease Testing Product
 Table 74. F. Hoffmann-La Roche Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 75. F. Hoffmann-La Roche Recent Development
 Table 76. Quest Diagnostics Company Details
 Table 77. Quest Diagnostics Business Overview
 Table 78. Quest Diagnostics Hereditary Disease Testing Product
 Table 79. Quest Diagnostics Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 80. Quest Diagnostics Recent Development
 Table 81. CooperSurgical Company Details
 Table 82. CooperSurgical Business Overview
 Table 83. CooperSurgical Hereditary Disease Testing Product
 Table 84. CooperSurgical Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 85. CooperSurgical Recent Development
 Table 86. Agilent Technologies Company Details
 Table 87. Agilent Technologies Business Overview
 Table 88. Agilent Technologies Hereditary Disease Testing Product
 Table 89. Agilent Technologies Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 90. Agilent Technologies Recent Development
 Table 91. Thermo Fisher Scientific Company Details
 Table 92. Thermo Fisher Scientific Business Overview
 Table 93. Thermo Fisher Scientific Hereditary Disease Testing Product
 Table 94. Thermo Fisher Scientific Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 95. Thermo Fisher Scientific Recent Development
 Table 96. Twist Bioscience Company Details
 Table 97. Twist Bioscience Business Overview
 Table 98. Twist Bioscience Hereditary Disease Testing Product
 Table 99. Twist Bioscience Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 100. Twist Bioscience Recent Development
 Table 101. Sophia Genetics Company Details
 Table 102. Sophia Genetics Business Overview
 Table 103. Sophia Genetics Hereditary Disease Testing Product
 Table 104. Sophia Genetics Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 105. Sophia Genetics Recent Development
 Table 106. Fulgent Genetic Company Details
 Table 107. Fulgent Genetic Business Overview
 Table 108. Fulgent Genetic Hereditary Disease Testing Product
 Table 109. Fulgent Genetic Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 110. Fulgent Genetic Recent Development
 Table 111. Medgenome Company Details
 Table 112. Medgenome Business Overview
 Table 113. Medgenome Hereditary Disease Testing Product
 Table 114. Medgenome Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 115. Medgenome Recent Development
 Table 116. CENTOGENE Company Details
 Table 117. CENTOGENE Business Overview
 Table 118. CENTOGENE Hereditary Disease Testing Product
 Table 119. CENTOGENE Revenue in Hereditary Disease Testing Business (2020-2025) & (US$ Million)
 Table 120. CENTOGENE Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Hereditary Disease Testing Picture
 Figure 2. Global Hereditary Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hereditary Disease Testing Market Share by Type: 2024 VS 2031
 Figure 4. Hereditary Cancer Testing Features
 Figure 5. Hereditary Non-cancer Testing Features
 Figure 6. Global Hereditary Disease Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hereditary Disease Testing Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Laboratory Case Studies
 Figure 11. Others Case Studies
 Figure 12. Hereditary Disease Testing Report Years Considered
 Figure 13. Global Hereditary Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Hereditary Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Hereditary Disease Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Hereditary Disease Testing Market Share by Players in 2024
 Figure 17. Global Top Hereditary Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Disease Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Hereditary Disease Testing Revenue in 2024
 Figure 19. North America Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Hereditary Disease Testing Market Share by Country (2020-2031)
 Figure 21. United States Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Hereditary Disease Testing Market Share by Country (2020-2031)
 Figure 25. Germany Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Hereditary Disease Testing Market Share by Region (2020-2031)
 Figure 33. China Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Hereditary Disease Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Hereditary Disease Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Hereditary Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Myriad Genetics Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 49. Invitae Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 50. Illumina Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 51. Natera Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 52. Laboratory Corporation of America Holdings Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 54. Quest Diagnostics Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 55. CooperSurgical Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 56. Agilent Technologies Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 58. Twist Bioscience Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 59. Sophia Genetics Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 60. Fulgent Genetic Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 61. Medgenome Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 62. CENTOGENE Revenue Growth Rate in Hereditary Disease Testing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart